Recent Posts
- Turret Capital Launches Sable, a Biotech-Driven Beauty Brand Advancing Body Contouring and Aesthetic Longevity
- Turret Capital Launches “The Foundry”: A Global Youth Innovation Platform to Shape the Future of Healthcare
- Egret Therapeutics Appoints Dr. Geoffrey Ling to Scientific Advisory Board
- Egret Therapeutics Announces Appointment Ron Cohen, M.D. to its Board of Directors
- Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
Recent Comments